Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples o...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/183653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554428295544832 |
---|---|
author | Mahmood M. T. M. Ally Bridget Hodkinson Pieter W. A. Meyer Eustasius Musenge Mohammed Tikly Ronald Anderson |
author_facet | Mahmood M. T. M. Ally Bridget Hodkinson Pieter W. A. Meyer Eustasius Musenge Mohammed Tikly Ronald Anderson |
author_sort | Mahmood M. T. M. Ally |
collection | DOAJ |
description | Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples of 128 disease-modifying, drug-naïve patients and analysed in relation to shared epitope genotype, a range of circulating chemokines/cytokines, acute phase reactants, autoantibodies, cartilage oligomeric protein (COMP), and the simplified disease activity index (SDAI). MMP-3 was elevated >1.86 ng/ml in 56.25% of patients (P<0.0001), correlated with several biomarkers, notably IL-8, IL-6, IFN γ, VEGF and COMP (r values = 0.22–0.33, P<0.014–0.0001) and with CRP and SAA levels (r=0.40 and 0.41, resp., P<0.0000) and SDAI (r=0.29, P<0.0001), but not with erosions or nodulosis. However, the correlations of CRP and SAA with SDAI were stronger (respective values of 0.63 and 0.54, P<0.001 for both). COMP correlated with smoking, RF, and MMP-3.
MMP-3 is significantly associated with disease activity, inflammatory mediators and cartilage breakdown, making it a potential biomarker of disease severity, but seemingly less useful than CRP and SAA as a biomarker of disease activity in early RA. |
format | Article |
id | doaj-art-7bddb762758b495cbb6da87890d79f7f |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-7bddb762758b495cbb6da87890d79f7f2025-02-03T05:51:35ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/183653183653Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid ArthritisMahmood M. T. M. Ally0Bridget Hodkinson1Pieter W. A. Meyer2Eustasius Musenge3Mohammed Tikly4Ronald Anderson5Department of Internal Medicine, Faculty of Health Sciences, University of Pretoria, Private Bag X663, Pretoria 0001, South AfricaDivision of Rheumatology, Department of Medicine, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South AfricaBiostatistics and Epidemiology Division, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDivision of Rheumatology, Department of Medicine, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South AfricaMatrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples of 128 disease-modifying, drug-naïve patients and analysed in relation to shared epitope genotype, a range of circulating chemokines/cytokines, acute phase reactants, autoantibodies, cartilage oligomeric protein (COMP), and the simplified disease activity index (SDAI). MMP-3 was elevated >1.86 ng/ml in 56.25% of patients (P<0.0001), correlated with several biomarkers, notably IL-8, IL-6, IFN γ, VEGF and COMP (r values = 0.22–0.33, P<0.014–0.0001) and with CRP and SAA levels (r=0.40 and 0.41, resp., P<0.0000) and SDAI (r=0.29, P<0.0001), but not with erosions or nodulosis. However, the correlations of CRP and SAA with SDAI were stronger (respective values of 0.63 and 0.54, P<0.001 for both). COMP correlated with smoking, RF, and MMP-3. MMP-3 is significantly associated with disease activity, inflammatory mediators and cartilage breakdown, making it a potential biomarker of disease severity, but seemingly less useful than CRP and SAA as a biomarker of disease activity in early RA.http://dx.doi.org/10.1155/2013/183653 |
spellingShingle | Mahmood M. T. M. Ally Bridget Hodkinson Pieter W. A. Meyer Eustasius Musenge Mohammed Tikly Ronald Anderson Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis Mediators of Inflammation |
title | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_full | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_fullStr | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_full_unstemmed | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_short | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_sort | serum matrix metalloproteinase 3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis |
url | http://dx.doi.org/10.1155/2013/183653 |
work_keys_str_mv | AT mahmoodmtmally serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT bridgethodkinson serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT pieterwameyer serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT eustasiusmusenge serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT mohammedtikly serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT ronaldanderson serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis |